Evaluation of marketing authorization and labels of medicines in 2021 WHO Model List of Essential Medicines for Children in China, the Russian Federation and Brazil

被引：0
|
作者：
Caiyun Li
Luyan Cheng
Xuefang Zhang
Lingli Zhang
Jianzhou Yan
机构：
[1] China Pharmaceutical University,School of International Pharmaceutical Business
[2] China Pharmaceutical University,The Research Center of National Drug Policy and Ecosystem
[3] Nanjing Medical University,School of Pharmacy
来源：
Health Research Policy and Systems | / 22卷
关键词：
Essential medicines for children; Drug labels; China; The Russian Federation; Brazil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 48 条
  • [31] National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
    Peacocke, Elizabeth F.
    Myhreid, Sonja L.
    Foss, Hakan Safaralilo
    Gopinathan, Unni
    PLOS MEDICINE, 2022, 19 (03)
  • [32] WHO Model Lists of Essential Medicines: methylphenidate for ADHD in children and adolescents
    Coghill, David
    Mattingly, Gregory W.
    Rohde, Luis A.
    Wong, Ian C. K.
    Faraone, Steven
    Cortese, Samuele
    LANCET PSYCHIATRY, 2023, 10 (10): : 743 - 744
  • [33] Evidence of clinical benefit of WHO essential anticancer medicines for children, 2011-2021
    Bai, Lin
    Zhan, Yuqi
    Zhou, Yue
    Zhang, Yichen
    Shi, Luwen
    Gupta, Sumit
    Denburg, Avram
    Guan, Xiaodong
    ECLINICALMEDICINE, 2023, 59
  • [34] Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports
    Mersiha Mahmić-Kaknjo
    Ana Marušić
    European Journal of Clinical Pharmacology, 2015, 71 : 825 - 833
  • [35] Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports
    Mahmic-Kaknjo, Mersiha
    Marusic, Ana
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (07) : 825 - 833
  • [36] Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review
    Rashed, Asia N.
    Jackson, Charlotte
    Gastine, Silke
    Hsia, Yingfen
    Bielicki, Julia
    Standing, Joseph F.
    Tomlin, Stephen
    Sharland, Mike
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (12) : 1099 - 1106
  • [37] Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?
    Logez, SMD
    Hutin, YJE
    Holloway, K
    Gray, R
    Hogerzeil, HV
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1106 - 1113
  • [38] Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
    Walsh, Jennifer
    Masini, Tiziana
    Huttner, Benedikt D.
    Moja, Lorenzo
    Penazzato, Martina
    Cappello, Bernadette
    PHARMACEUTICS, 2022, 14 (03)
  • [39] Availability and accessibility of cytotoxic medicines in the WHO model list of essential medicines for childhood cancer in low and lower-middle- income countries: a systematic review
    Maheeka Seneviwickrama
    Sashini Shehana Denagamagei
    Surangi Jayakody
    Sanjeeva Gunasekera
    Guwani Liyanage
    BMC Cancer, 25 (1)
  • [40] Are age-appropriate antibiotic formulations missing from the WHO list of essential medicines for children? A comparison study
    Ivanovska, Verica
    Leufkens, Hubert G.
    Rademaker, Carin M. A.
    Zisovska, Elizabeta
    Pijnenburg, Marielle W.
    van Dijk, Liset
    Mantel-Teeuwisse, Aukje K.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2017, 102 (04) : 352 - 356
12345